Elodie Segura

Elodie Segura was trained at Institut Curie (Paris) as a PhD student with Clotilde Théry and at the Walter and Eliza Hall Institute (Melbourne) as a post-doc with José Villadangos. She obtained a permanent position at INSERM in France in 2012 and is a Principal Investigator at the Immunology Department of Institut Curie (Paris) since 2017. She is a member of the ‘EMBO Young Investigator’ network.

Her lab focuses on the biology of mononuclear phagocytes (dendritic cells, macrophages and monocytes), with the goal to manipulate the properties of these cells for disease treatment, in particular for cancer and inflammatory diseases. A major aim of her work is to better understand how mononuclear phagocytes adapt their transcriptional program to signals from their environment, notably via the Aryl Hydrocarbon Receptor. To achieve this, her group combines studies of human cells in vitro and relevant in vivo models in mice.